Antileishmanial activity of the violacein extracted from Chromobacterium violaceum

Violacein improves vemurafenib response in melanoma spheroids.

Natural product research·2023

New synthetic nano-immunotherapy (OncoTherad®) for non-muscle invasive bladder cancer: Its synthesis, characterization and anticancer property.

Tissue & cell·2022

Violacein and its antifungal activity: comments and potentialities.

Letters in applied microbiology·2022

OncoTherad® (MRB-CFI-1) nano-immunotherapy reduced tumoral progression in non-muscle invasive bladder cancer through activation of Toll-like signaling pathway.

Tissue & cell·2022

Design of magnetic hybrid nanostructured lipid carriers containing 1,8-cineole as delivery systems for anticancer drugs: Physicochemical and cytotoxic studies.

Colloids and surfaces. B, Biointerfaces·2021

Evaluation of oral streptococci in saliva of children with severe Early Childhood Caries and caries-free.

European journal of paediatric dentistry·2020

HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy.

The Journal of antimicrobial chemotherapy·2026

Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.

The Journal of antimicrobial chemotherapy·2026

Efficacy of new antimicrobial agents against carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacterales in Japan: national genomic surveillance (JARBS 2.0) study.

The Journal of antimicrobial chemotherapy·2026

A prospective pharmacokinetic interaction study between rifampicin and fusidic acid for the treatment of staphylococcal infections.

The Journal of antimicrobial chemotherapy·2026

Assessment of Enterococcus faecalis biofilm response to amoxicillin and ciprofloxacin using a dynamic in vitro pharmacokinetic-pharmacodynamic model of catheter-associated urinary tract infection.

The Journal of antimicrobial chemotherapy·2026

In-hospital antibiotic consumption in Lombardy, Italy (2017-2024): a retrospective analysis of regional administrative data.

The Journal of antimicrobial chemotherapy·2026

1-Azabicyclo[1.1.0]butanes (ABBs) on the Map: Mechanistic Pathways for Catalytic Ring Opening and Functionalizations.

Angewandte Chemie (International ed. in English)·2026

Redirecting Regioselectivity in Cytochrome P450 ApPT for B-Ring Functionalization of Pentacyclic Triterpenoids.

Angewandte Chemie (International ed. in English)·2026

Carbon Dots as Versatile Nanoplatforms for Ophthalmic Therapeutics.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2026

The phytochemistry and pharmacological activities of Clinacanthus nutans (Burm. f.) Lindau: current evidence, mechanistic insights, and future therapeutic perspectives.

Frontiers in pharmacology·2026

Novel bis(benzylidene)-6-methyl-2-thiouracil derivatives: design, synthesis, and molecular docking as potential antimicrobial agents against multidrug-resistant pathogenic bacteria.

RSC advances·2026

Triazole-based hybrid molecules in anticancer drug discovery: structural classes and mechanistic insights, 2014-2025.

Beilstein journal of organic chemistry·2026

Related Experiment Videos

Antileishmanial activity of the violacein extracted from Chromobacterium violaceum

Related Concept Videos

Violacein improves vemurafenib response in melanoma spheroids.

New synthetic nano-immunotherapy (OncoTherad®) for non-muscle invasive bladder cancer: Its synthesis, characterization and anticancer property.

Violacein and its antifungal activity: comments and potentialities.

OncoTherad® (MRB-CFI-1) nano-immunotherapy reduced tumoral progression in non-muscle invasive bladder cancer through activation of Toll-like signaling pathway.

Design of magnetic hybrid nanostructured lipid carriers containing 1,8-cineole as delivery systems for anticancer drugs: Physicochemical and cytotoxic studies.

Evaluation of oral streptococci in saliva of children with severe Early Childhood Caries and caries-free.

HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy.

Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.

Efficacy of new antimicrobial agents against carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacterales in Japan: national genomic surveillance (JARBS 2.0) study.

A prospective pharmacokinetic interaction study between rifampicin and fusidic acid for the treatment of staphylococcal infections.

Assessment of Enterococcus faecalis biofilm response to amoxicillin and ciprofloxacin using a dynamic in vitro pharmacokinetic-pharmacodynamic model of catheter-associated urinary tract infection.

In-hospital antibiotic consumption in Lombardy, Italy (2017-2024): a retrospective analysis of regional administrative data.

1-Azabicyclo[1.1.0]butanes (ABBs) on the Map: Mechanistic Pathways for Catalytic Ring Opening and Functionalizations.

Redirecting Regioselectivity in Cytochrome P450 ApPT for B-Ring Functionalization of Pentacyclic Triterpenoids.

Carbon Dots as Versatile Nanoplatforms for Ophthalmic Therapeutics.

The phytochemistry and pharmacological activities of Clinacanthus nutans (Burm. f.) Lindau: current evidence, mechanistic insights, and future therapeutic perspectives.

Novel bis(benzylidene)-6-methyl-2-thiouracil derivatives: design, synthesis, and molecular docking as potential antimicrobial agents against multidrug-resistant pathogenic bacteria.

Triazole-based hybrid molecules in anticancer drug discovery: structural classes and mechanistic insights, 2014-2025.

Related Experiment Videos

Antileishmanial activity of the violacein extracted from Chromobacterium violaceum

Related Concept Videos

Related Articles